Edison Inks Potential $4.3B R&D Deal With Japan Pharma Co.
California-based Edison Pharmaceuticals Inc. said Friday that it has entered into a strategic alliance with Japan's Dainippon Sumitomo Pharma Co. Ltd. potentially worth up to $4.3 billion to develop drugs targeting...To view the full article, register now.
Already a subscriber? Click here to view full article